Publisher: John Wiley & Sons Inc
E-ISSN: 1365-2222|45|10|1510-1522
ISSN: 0954-7894
Source: CLINICAL & EXPERIMENTAL ALLERGY, Vol.45, Iss.10, 2015-10, pp. : 1510-1522
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
SummaryActivin A, a member of the TGF‐β superfamily of cytokines, was originally identified as an inducer of follicle stimulating hormone release, but has since been ascribed roles in normal physiological processes, as an immunoregulatory cytokine and as a driver of fibrosis. In the last 10–15 years, it has also become abundantly clear that activin A plays an important role in the regulation of asthmatic inflammation and airway remodelling. This review provides a brief introduction to the activin A/TGF‐β superfamily, focussing on the regulation of receptors and signalling pathways. We examine the contradictory evidence for generalized pro‐ vs. anti‐inflammatory effects of activin A in inflammation, before appraising its role in asthmatic inflammation and airway remodelling specifically by evaluating data from both murine models and clinical studies. We identify key issues to be addressed, paving the way for safe exploitation of modulation of activin A function for treatment of allergic asthma and other inflammatory lung diseases.
Related content
The immunoregulatory and fibrotic roles of activin A in allergic asthma
CLINICAL & EXPERIMENTAL ALLERGY, Vol. 954-7894, Iss. 10, 2015-10 ,pp. :
Montelukast in the treatment of asthma and allergic rhinitis
By Neighbour Helen McIvor Andrew
Clinical Practice, Vol. 10, Iss. 3, 2013-05 ,pp. :
Role of Interferon-λ in Allergic Asthma
Journal of Innate Immunity, Vol. 7, Iss. 3, 2015-01 ,pp. :
Serum Chitotriosidase Levels in Patients with Allergic and Non-Allergic Asthma
Respiration, Vol. 79, Iss. 5, 2010-01 ,pp. :
Future and experimental therapeutic strategies for allergic rhinitis and asthma
Therapy, Vol. 1, Iss. 2, 2004-11 ,pp. :